• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Melatonin Inovamed 2 mg
    / Inovamed Pharma Ltd.


    Active Ingredient
    Melatonin 2 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Prolonged-Release Tablets

    30 X 2 mg

    not in the basket chart

    Related information


    Dosage

    The recommended dose is one tablet per day (2 mg), after food, 1-2 hours before bedtime. You may continue this dosage for a period of up to 13 weeks.


    Indications

    Short-term treatment of primary insomnia (sleeplessness, difficulty falling asleep or staying asleep or poor quality of sleep), in patients aged 55 and over. Insomnia is defined as ‘primary’ when it is not the result of an identified cause, such as a medical, mental or environmental condition.


    Contra-Indications

    Hypersensitivity to the active substance or to any of the excipients.


    Special Precautions

    Please refer to the license holder for further details.


    Side Effects

    Please refer to the license holder for further details.


    Drug interactions

    Please refer to the license holder for further details.


    Pregnancy and Lactation

    Please refer to the license holder for further details.


    Overdose

    Please refer to the license holder for further details.


    Manufacturer
    Aurobindo Pharma, India
    Licence holder

    סרגל נגישות

    CLOSE